カテゴリ： QYResearch, 世界, 医療/バイオ

吸入器＆ネブライザーの世界市場2023年：吸入器、ネブライザー

■ 英語タイトル：Global Inhalers and Nebulizers Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7988）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7988
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[吸入器＆ネブライザーの世界市場2023年：吸入器、ネブライザー]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は吸入器＆ネブライザーのグローバル市場について調査・分析し、世界の吸入器＆ネブライザー市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（吸入器、ネブライザー）、用途別セグメント分析（喘息、COPD、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GSK、AstraZeneca、Chiesi、Boehringer Ingelheim、Novartis、Teva、Organon、PARI GmbH、Omron、Philips、Drive DeVilbiss Healthcare、Yuwell、Leyi、Folee、Beurerなどが含まれています。吸入器＆ネブライザーのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、吸入器＆ネブライザー市場規模を算出する際に考慮しました。

・吸入器＆ネブライザー市場の概要
- 製品の定義
- 吸入器＆ネブライザーの種類別セグメント
- 世界の吸入器＆ネブライザー市場規模：タイプ別分析（吸入器、ネブライザー）
- 吸入器＆ネブライザーの用途別セグメント
- 世界の吸入器＆ネブライザー市場規模：用途別分析（喘息、COPD、その他）
- 世界の吸入器＆ネブライザー市場規模予測（2018年-2029年）
- 吸入器＆ネブライザーの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 吸入器＆ネブライザー市場の競争状況およびトレンド

・吸入器＆ネブライザーの地域別市場規模
- 北米の吸入器＆ネブライザー市場規模（2018年-2029年）
- 米国の吸入器＆ネブライザー市場規模（2018年-2029年）
- ヨーロッパの吸入器＆ネブライザー市場規模（2018年-2029年）
- アジア太平洋の吸入器＆ネブライザー市場規模（2018年-2029年）
- 中国の吸入器＆ネブライザー市場規模（2018年-2029年）
- 日本の吸入器＆ネブライザー市場規模（2018年-2029年）
- 韓国の吸入器＆ネブライザー市場規模（2018年-2029年）
- インドの吸入器＆ネブライザー市場規模（2018年-2029年）
- オーストラリアの吸入器＆ネブライザー市場規模（2018年-2029年）
- 中南米の吸入器＆ネブライザー市場規模（2018年-2029年）
- 中東・アフリカの吸入器＆ネブライザー市場規模（2018年-2029年）

・種類別セグメント：吸入器、ネブライザー
- 世界の吸入器＆ネブライザーのタイプ別販売量（2018年-2023年）
- 世界の吸入器＆ネブライザーのタイプ別売上（2018年-2023年）
- 世界の吸入器＆ネブライザーのタイプ別価格

・用途別セグメント：喘息、COPD、その他
- 世界の吸入器＆ネブライザーの用途別販売量（2018年-2023年）
- 世界の吸入器＆ネブライザーの用途別売上（2018年-2023年）
- 世界の吸入器＆ネブライザーの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
GSK、AstraZeneca、Chiesi、Boehringer Ingelheim、Novartis、Teva、Organon、PARI GmbH、Omron、Philips、Drive DeVilbiss Healthcare、Yuwell、Leyi、Folee、Beurer

・産業チェーンと販売チャネルの分析
- 吸入器＆ネブライザー産業チェーン分析
- 吸入器＆ネブライザーの主要原材料
- 吸入器＆ネブライザーの販売チャネル
- 吸入器＆ネブライザーのディストリビューター
- 吸入器＆ネブライザーの主要顧客

・吸入器＆ネブライザー市場ダイナミクス
- 吸入器＆ネブライザーの業界動向
- 吸入器＆ネブライザー市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Inhalers and nebulizers are two different devices used to deliver quick-relief medicines (also called rescue or fast-acting medicines) or long-term control medicines (also called controller or maintenance medicines) directly into the lungs
Highlights
The global Inhalers and Nebulizers market was valued at US$ 14010 million in 2022 and is anticipated to reach US$ 18410 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva, etc. Global top five manufacturers hold a share about 75%. North America is the largest market of Inhalers and Nebulizers, holds a share over 35%. In terms of product, the Inhalers holds a share of over 90%. And in terms of application, the largest application field is Asthma, with a share of over 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhalers and Nebulizers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalers and Nebulizers.
The Inhalers and Nebulizers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Inhalers and Nebulizers market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalers and Nebulizers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GSK
AstraZeneca
Chiesi
Boehringer Ingelheim
Novartis
Teva
Organon
PARI GmbH
Omron
Philips
Drive DeVilbiss Healthcare
Yuwell
Leyi
Folee
Beurer
Segment by Type
Inhalers
Nebulizer
Segment by Application
Asthma
COPD
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalers and Nebulizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalers and Nebulizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Inhalers and Nebulizers market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalers and Nebulizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Inhalers and Nebulizers and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Inhalers and Nebulizers industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalers and Nebulizers.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalers and Nebulizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalers and Nebulizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Inhalers and Nebulizers Market Overview
1.1 Product Overview and Scope of Inhalers and Nebulizers
1.2 Inhalers and Nebulizers Segment by Type
1.2.1 Global Inhalers and Nebulizers Market Value Comparison by Type (2023-2029)
1.2.2 Inhalers
1.2.3 Nebulizer
1.3 Inhalers and Nebulizers Segment by Application
1.3.1 Global Inhalers and Nebulizers Market Value by Application: (2023-2029)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Inhalers and Nebulizers Market Size Estimates and Forecasts
1.4.1 Global Inhalers and Nebulizers Revenue 2018-2029
1.4.2 Global Inhalers and Nebulizers Sales 2018-2029
1.4.3 Global Inhalers and Nebulizers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Inhalers and Nebulizers Market Competition by Manufacturers
2.1 Global Inhalers and Nebulizers Sales Market Share by Manufacturers (2018-2023)
2.2 Global Inhalers and Nebulizers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Inhalers and Nebulizers Average Price by Manufacturers (2018-2023)
2.4 Global Inhalers and Nebulizers Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Inhalers and Nebulizers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalers and Nebulizers, Product Type & Application
2.7 Inhalers and Nebulizers Market Competitive Situation and Trends
2.7.1 Inhalers and Nebulizers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhalers and Nebulizers Players Market Share by Revenue
2.7.3 Global Inhalers and Nebulizers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhalers and Nebulizers Retrospective Market Scenario by Region
3.1 Global Inhalers and Nebulizers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inhalers and Nebulizers Global Inhalers and Nebulizers Sales by Region: 2018-2029
3.2.1 Global Inhalers and Nebulizers Sales by Region: 2018-2023
3.2.2 Global Inhalers and Nebulizers Sales by Region: 2024-2029
3.3 Global Inhalers and Nebulizers Global Inhalers and Nebulizers Revenue by Region: 2018-2029
3.3.1 Global Inhalers and Nebulizers Revenue by Region: 2018-2023
3.3.2 Global Inhalers and Nebulizers Revenue by Region: 2024-2029
3.4 North America Inhalers and Nebulizers Market Facts & Figures by Country
3.4.1 North America Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inhalers and Nebulizers Sales by Country (2018-2029)
3.4.3 North America Inhalers and Nebulizers Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalers and Nebulizers Market Facts & Figures by Country
3.5.1 Europe Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inhalers and Nebulizers Sales by Country (2018-2029)
3.5.3 Europe Inhalers and Nebulizers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalers and Nebulizers Market Facts & Figures by Country
3.6.1 Asia Pacific Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inhalers and Nebulizers Sales by Country (2018-2029)
3.6.3 Asia Pacific Inhalers and Nebulizers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhalers and Nebulizers Market Facts & Figures by Country
3.7.1 Latin America Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inhalers and Nebulizers Sales by Country (2018-2029)
3.7.3 Latin America Inhalers and Nebulizers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalers and Nebulizers Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalers and Nebulizers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inhalers and Nebulizers Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inhalers and Nebulizers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalers and Nebulizers Sales by Type (2018-2029)
4.1.1 Global Inhalers and Nebulizers Sales by Type (2018-2023)
4.1.2 Global Inhalers and Nebulizers Sales by Type (2024-2029)
4.1.3 Global Inhalers and Nebulizers Sales Market Share by Type (2018-2029)
4.2 Global Inhalers and Nebulizers Revenue by Type (2018-2029)
4.2.1 Global Inhalers and Nebulizers Revenue by Type (2018-2023)
4.2.2 Global Inhalers and Nebulizers Revenue by Type (2024-2029)
4.2.3 Global Inhalers and Nebulizers Revenue Market Share by Type (2018-2029)
4.3 Global Inhalers and Nebulizers Price by Type (2018-2029)
5 Segment by Application
5.1 Global Inhalers and Nebulizers Sales by Application (2018-2029)
5.1.1 Global Inhalers and Nebulizers Sales by Application (2018-2023)
5.1.2 Global Inhalers and Nebulizers Sales by Application (2024-2029)
5.1.3 Global Inhalers and Nebulizers Sales Market Share by Application (2018-2029)
5.2 Global Inhalers and Nebulizers Revenue by Application (2018-2029)
5.2.1 Global Inhalers and Nebulizers Revenue by Application (2018-2023)
5.2.2 Global Inhalers and Nebulizers Revenue by Application (2024-2029)
5.2.3 Global Inhalers and Nebulizers Revenue Market Share by Application (2018-2029)
5.3 Global Inhalers and Nebulizers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Inhalers and Nebulizers Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Inhalers and Nebulizers Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Chiesi
6.3.1 Chiesi Corporation Information
6.3.2 Chiesi Description and Business Overview
6.3.3 Chiesi Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Chiesi Inhalers and Nebulizers Product Portfolio
6.3.5 Chiesi Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim Inhalers and Nebulizers Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novartis Inhalers and Nebulizers Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Inhalers and Nebulizers Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Organon
6.6.1 Organon Corporation Information
6.6.2 Organon Description and Business Overview
6.6.3 Organon Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Organon Inhalers and Nebulizers Product Portfolio
6.7.5 Organon Recent Developments/Updates
6.8 PARI GmbH
6.8.1 PARI GmbH Corporation Information
6.8.2 PARI GmbH Description and Business Overview
6.8.3 PARI GmbH Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 PARI GmbH Inhalers and Nebulizers Product Portfolio
6.8.5 PARI GmbH Recent Developments/Updates
6.9 Omron
6.9.1 Omron Corporation Information
6.9.2 Omron Description and Business Overview
6.9.3 Omron Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Omron Inhalers and Nebulizers Product Portfolio
6.9.5 Omron Recent Developments/Updates
6.10 Philips
6.10.1 Philips Corporation Information
6.10.2 Philips Description and Business Overview
6.10.3 Philips Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Philips Inhalers and Nebulizers Product Portfolio
6.10.5 Philips Recent Developments/Updates
6.11 Drive DeVilbiss Healthcare
6.11.1 Drive DeVilbiss Healthcare Corporation Information
6.11.2 Drive DeVilbiss Healthcare Inhalers and Nebulizers Description and Business Overview
6.11.3 Drive DeVilbiss Healthcare Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Drive DeVilbiss Healthcare Inhalers and Nebulizers Product Portfolio
6.11.5 Drive DeVilbiss Healthcare Recent Developments/Updates
6.12 Yuwell
6.12.1 Yuwell Corporation Information
6.12.2 Yuwell Inhalers and Nebulizers Description and Business Overview
6.12.3 Yuwell Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yuwell Inhalers and Nebulizers Product Portfolio
6.12.5 Yuwell Recent Developments/Updates
6.13 Leyi
6.13.1 Leyi Corporation Information
6.13.2 Leyi Inhalers and Nebulizers Description and Business Overview
6.13.3 Leyi Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Leyi Inhalers and Nebulizers Product Portfolio
6.13.5 Leyi Recent Developments/Updates
6.14 Folee
6.14.1 Folee Corporation Information
6.14.2 Folee Inhalers and Nebulizers Description and Business Overview
6.14.3 Folee Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Folee Inhalers and Nebulizers Product Portfolio
6.14.5 Folee Recent Developments/Updates
6.15 Beurer
6.15.1 Beurer Corporation Information
6.15.2 Beurer Inhalers and Nebulizers Description and Business Overview
6.15.3 Beurer Inhalers and Nebulizers Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Beurer Inhalers and Nebulizers Product Portfolio
6.15.5 Beurer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalers and Nebulizers Industry Chain Analysis
7.2 Inhalers and Nebulizers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalers and Nebulizers Production Mode & Process
7.4 Inhalers and Nebulizers Sales and Marketing
7.4.1 Inhalers and Nebulizers Sales Channels
7.4.2 Inhalers and Nebulizers Distributors
7.5 Inhalers and Nebulizers Customers
8 Inhalers and Nebulizers Market Dynamics
8.1 Inhalers and Nebulizers Industry Trends
8.2 Inhalers and Nebulizers Market Drivers
8.3 Inhalers and Nebulizers Market Challenges
8.4 Inhalers and Nebulizers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Inhalers and Nebulizers Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Inhalers and Nebulizers Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Inhalers and Nebulizers Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inhalers and Nebulizers Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Inhalers and Nebulizers Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Inhalers and Nebulizers Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Inhalers and Nebulizers Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Inhalers and Nebulizers Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Inhalers and Nebulizers, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Inhalers and Nebulizers, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhalers and Nebulizers, Product Type & Application
Table 12. Global Key Manufacturers of Inhalers and Nebulizers, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhalers and Nebulizers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalers and Nebulizers as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalers and Nebulizers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inhalers and Nebulizers Sales by Region (2018-2023) & (K Units)
Table 18. Global Inhalers and Nebulizers Sales Market Share by Region (2018-2023)
Table 19. Global Inhalers and Nebulizers Sales by Region (2024-2029) & (K Units)
Table 20. Global Inhalers and Nebulizers Sales Market Share by Region (2024-2029)
Table 21. Global Inhalers and Nebulizers Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Inhalers and Nebulizers Revenue Market Share by Region (2018-2023)
Table 23. Global Inhalers and Nebulizers Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inhalers and Nebulizers Revenue Market Share by Region (2024-2029)
Table 25. North America Inhalers and Nebulizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inhalers and Nebulizers Sales by Country (2018-2023) & (K Units)
Table 27. North America Inhalers and Nebulizers Sales by Country (2024-2029) & (K Units)
Table 28. North America Inhalers and Nebulizers Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Inhalers and Nebulizers Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inhalers and Nebulizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inhalers and Nebulizers Sales by Country (2018-2023) & (K Units)
Table 32. Europe Inhalers and Nebulizers Sales by Country (2024-2029) & (K Units)
Table 33. Europe Inhalers and Nebulizers Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Inhalers and Nebulizers Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inhalers and Nebulizers Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inhalers and Nebulizers Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Inhalers and Nebulizers Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Inhalers and Nebulizers Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Inhalers and Nebulizers Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inhalers and Nebulizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inhalers and Nebulizers Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Inhalers and Nebulizers Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Inhalers and Nebulizers Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Inhalers and Nebulizers Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inhalers and Nebulizers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inhalers and Nebulizers Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Inhalers and Nebulizers Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Inhalers and Nebulizers Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Inhalers and Nebulizers Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inhalers and Nebulizers Sales (K Units) by Type (2018-2023)
Table 51. Global Inhalers and Nebulizers Sales (K Units) by Type (2024-2029)
Table 52. Global Inhalers and Nebulizers Sales Market Share by Type (2018-2023)
Table 53. Global Inhalers and Nebulizers Sales Market Share by Type (2024-2029)
Table 54. Global Inhalers and Nebulizers Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Inhalers and Nebulizers Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inhalers and Nebulizers Revenue Market Share by Type (2018-2023)
Table 57. Global Inhalers and Nebulizers Revenue Market Share by Type (2024-2029)
Table 58. Global Inhalers and Nebulizers Price (US$/Unit) by Type (2018-2023)
Table 59. Global Inhalers and Nebulizers Price (US$/Unit) by Type (2024-2029)
Table 60. Global Inhalers and Nebulizers Sales (K Units) by Application (2018-2023)
Table 61. Global Inhalers and Nebulizers Sales (K Units) by Application (2024-2029)
Table 62. Global Inhalers and Nebulizers Sales Market Share by Application (2018-2023)
Table 63. Global Inhalers and Nebulizers Sales Market Share by Application (2024-2029)
Table 64. Global Inhalers and Nebulizers Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Inhalers and Nebulizers Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inhalers and Nebulizers Revenue Market Share by Application (2018-2023)
Table 67. Global Inhalers and Nebulizers Revenue Market Share by Application (2024-2029)
Table 68. Global Inhalers and Nebulizers Price (US$/Unit) by Application (2018-2023)
Table 69. Global Inhalers and Nebulizers Price (US$/Unit) by Application (2024-2029)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. GSK Inhalers and Nebulizers Product
Table 74. GSK Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca Inhalers and Nebulizers Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Chiesi Corporation Information
Table 81. Chiesi Description and Business Overview
Table 82. Chiesi Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Chiesi Inhalers and Nebulizers Product
Table 84. Chiesi Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Boehringer Ingelheim Inhalers and Nebulizers Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Novartis Inhalers and Nebulizers Product
Table 94. Novartis Recent Developments/Updates
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Teva Inhalers and Nebulizers Product
Table 99. Teva Recent Developments/Updates
Table 100. Organon Corporation Information
Table 101. Organon Description and Business Overview
Table 102. Organon Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Organon Inhalers and Nebulizers Product
Table 104. Organon Recent Developments/Updates
Table 105. PARI GmbH Corporation Information
Table 106. PARI GmbH Description and Business Overview
Table 107. PARI GmbH Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. PARI GmbH Inhalers and Nebulizers Product
Table 109. PARI GmbH Recent Developments/Updates
Table 110. Omron Corporation Information
Table 111. Omron Description and Business Overview
Table 112. Omron Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Omron Inhalers and Nebulizers Product
Table 114. Omron Recent Developments/Updates
Table 115. Philips Corporation Information
Table 116. Philips Description and Business Overview
Table 117. Philips Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Philips Inhalers and Nebulizers Product
Table 119. Philips Recent Developments/Updates
Table 120. Drive DeVilbiss Healthcare Corporation Information
Table 121. Drive DeVilbiss Healthcare Description and Business Overview
Table 122. Drive DeVilbiss Healthcare Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Drive DeVilbiss Healthcare Inhalers and Nebulizers Product
Table 124. Drive DeVilbiss Healthcare Recent Developments/Updates
Table 125. Yuwell Corporation Information
Table 126. Yuwell Description and Business Overview
Table 127. Yuwell Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Yuwell Inhalers and Nebulizers Product
Table 129. Yuwell Recent Developments/Updates
Table 130. Leyi Corporation Information
Table 131. Leyi Description and Business Overview
Table 132. Leyi Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Leyi Inhalers and Nebulizers Product
Table 134. Leyi Recent Developments/Updates
Table 135. Folee Corporation Information
Table 136. Folee Description and Business Overview
Table 137. Folee Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Folee Inhalers and Nebulizers Product
Table 139. Folee Recent Developments/Updates
Table 140. Beurer Corporation Information
Table 141. Beurer Description and Business Overview
Table 142. Beurer Inhalers and Nebulizers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Beurer Inhalers and Nebulizers Product
Table 144. Beurer Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Inhalers and Nebulizers Distributors List
Table 148. Inhalers and Nebulizers Customers List
Table 149. Inhalers and Nebulizers Market Trends
Table 150. Inhalers and Nebulizers Market Drivers
Table 151. Inhalers and Nebulizers Market Challenges
Table 152. Inhalers and Nebulizers Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhalers and Nebulizers
Figure 2. Global Inhalers and Nebulizers Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Inhalers and Nebulizers Market Share by Type in 2022 & 2029
Figure 4. Inhalers Product Picture
Figure 5. Nebulizer Product Picture
Figure 6. Global Inhalers and Nebulizers Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Inhalers and Nebulizers Market Share by Application in 2022 & 2029
Figure 8. Asthma
Figure 9. COPD
Figure 10. Others
Figure 11. Global Inhalers and Nebulizers Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Inhalers and Nebulizers Market Size (2018-2029) & (US$ Million)
Figure 13. Global Inhalers and Nebulizers Sales (2018-2029) & (K Units)
Figure 14. Global Inhalers and Nebulizers Average Price (US$/Unit) & (2018-2029)
Figure 15. Inhalers and Nebulizers Report Years Considered
Figure 16. Inhalers and Nebulizers Sales Share by Manufacturers in 2022
Figure 17. Global Inhalers and Nebulizers Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Inhalers and Nebulizers Players: Market Share by Revenue in 2022
Figure 19. Inhalers and Nebulizers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Inhalers and Nebulizers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Inhalers and Nebulizers Sales Market Share by Country (2018-2029)
Figure 22. North America Inhalers and Nebulizers Revenue Market Share by Country (2018-2029)
Figure 23. United States Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Inhalers and Nebulizers Sales Market Share by Country (2018-2029)
Figure 26. Europe Inhalers and Nebulizers Revenue Market Share by Country (2018-2029)
Figure 27. Germany Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Inhalers and Nebulizers Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Inhalers and Nebulizers Revenue Market Share by Region (2018-2029)
Figure 34. China Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Inhalers and Nebulizers Sales Market Share by Country (2018-2029)
Figure 44. Latin America Inhalers and Nebulizers Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Inhalers and Nebulizers Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Inhalers and Nebulizers Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Inhalers and Nebulizers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Inhalers and Nebulizers by Type (2018-2029)
Figure 54. Global Revenue Market Share of Inhalers and Nebulizers by Type (2018-2029)
Figure 55. Global Inhalers and Nebulizers Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Inhalers and Nebulizers by Application (2018-2029)
Figure 57. Global Revenue Market Share of Inhalers and Nebulizers by Application (2018-2029)
Figure 58. Global Inhalers and Nebulizers Price (US$/Unit) by Application (2018-2029)
Figure 59. Inhalers and Nebulizers Value Chain
Figure 60. Inhalers and Nebulizers Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • COPD＆喘息用デバイスのグローバル市場：吸入器、ネブライザー
  • デジタル呼吸装置の世界市場2023-2029：センサ、スマート吸入器、ネブライザー、その他
  • 世界の小児用在宅医療機器市場2022年ｰ2031年：製品別（人工呼吸器、監視システム、加温式加湿器、吸引装置、酸素供給装置、食品 & IVポンプ、ネブライザー、その他）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7988 )"吸入器＆ネブライザーの世界市場2023年：吸入器、ネブライザー" (英文：Global Inhalers and Nebulizers Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。